The Patent Finder

Transderm, Inc.

Also on record
Records under this name other than the patents Transderm, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 5 of 5 · Back to Transderm, Inc.

PatentTitleStatus Expires Confidence
US 9,855,252Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,205,080Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,172,789Compositions for transdermal delivery of mTOR inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,723,314Methods and compositions for treating pachyonychia congenita
Formerly held
In force
Term ended Nov 8, 2026 · From the USPTO record
In forceTerm ended Nov 8, 2026From the USPTO record
US 10,695,548GENE SILENCING IN SKIN USING SELF-DELIVERY siRNA DELIVERED BY A MESO DEVICE
Lapsed on the fee record
Ended Jun 30, 2024 · Medium confidence
Lapsed on the fee recordEnded Jun 30, 2024Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited